Pfizer
PulseAugur coverage of Pfizer — every cluster mentioning Pfizer across labs, papers, and developer communities, ranked by signal.
- employs Albert Bourla 100%
- employs Susan Desmond-Hellmann 100%
- subsidiary of BlackRock 100%
- subsidiary of State Street Corporation 100%
- subsidiary of The Vanguard Group 100%
- employs Shantanu Narayen 100%
- parent of Coty 100%
- parent of Zoetis 100%
- employed by Matt Friend 90%
- employed by Nike 90%
- developed by United States Food and Drug Administration 90%
- partners with Eli Lilly and Company 70%
10 day(s) with sentiment data
-
AlgoVault launches audited crypto trade call API with 91.8% win rate
AlgoVault has launched an API for crypto trade calls that provides an audited win rate, addressing the issue of self-reported metrics in the industry. Each trade call is hashed at generation and anchored to the Base L2 …
-
AlgoVault reports 91.8% win rate on 457k+ trade calls
AlgoVault's weekly trade-call report for the week of August 9, 2026, indicates a 91.8% win rate across over 1560 assets, with a notable 100.0% win rate for MBABYDOGE 3m. The system tracked 457,240 trade calls, with its …
-
AI Strategy Failure Rooted in Leadership's 'Belief Gap', Not Design
AI strategies often fail not due to poor design or technology, but because leaders cannot foster belief within their teams. This "belief gap" prevents adoption, as employees may fear AI's impact on their jobs and profes…
-
Pfizer beats earnings, AI firm raises funds, DeepSeek tops call volume
Pfizer reported second-quarter revenue of $15.03 billion, exceeding analyst expectations of $14.41 billion. In other news, AI company Kaiwang Data secured over 100 million yuan in a new strategic funding round led by Be…
-
AlgoVault tracks 435K trade calls, reports 91.7% PFE win rate
AlgoVault Labs has reported tracking over 435,000 trade calls for the week of August 2, 2026. Their system achieved a 91.7% win rate for Pfizer (PFE) across more than 1496 assets, with a notable 100.0% win rate for COIN…
-
AI accelerates drug discovery, but data quality and lab bottlenecks remain challenges · 4 sources tracked
Artificial intelligence is accelerating drug discovery by enabling predictive design of drug candidates, which reduces the need for extensive physical screening. However, this speed highlights bottlenecks in laboratory …
-
CME Group launches single-stock futures for 50+ U.S. stocks
CME Group is launching single-stock futures for over 50 of the largest U.S. companies, including NVIDIA and SpaceX, allowing investors to speculate or hedge without trading shares. These cash-settled contracts offer lev…
-
Revolution Medicines' cancer drug shows promise, sparking debate on US innovation model
A new drug, daraxonrasib from Revolution Medicines, has shown unprecedented success in nearly doubling survival rates for pancreatic cancer patients, eliciting a strong positive reaction from the medical community. This…
-
Warren Buffett warns against speculative investing, highlighting biotech's gambling-like risks
Warren Buffett has cautioned against the increasing speculative nature of the stock market, drawing a parallel to the biotechnology sector. He noted that while he prefers businesses he can understand with predictable ca…
-
Ant Group invests in Bohe Health to boost AI-driven weight management
Ant Group has invested over 28% in Bohe Health, a company focused on weight management and healthy eating, becoming its largest external shareholder. This strategic investment aims to leverage Bohe Health's extensive us…
-
AlgoVault launches AI agent-focused MCP server for financial market data
AlgoVault has released an MCP server designed for AI agents to use for financial market data, aiming to provide actionable trading decisions rather than just raw data. The server offers a composite BUY/SELL/HOLD verdict…
-
Nike pays premium for battle-tested CFO amid turnaround efforts
Companies are increasingly offering substantial compensation packages to attract experienced Chief Financial Officers (CFOs), a trend driven by a scarcity of proven talent. Nike's recent hiring of David Denton from Pfiz…
-
NYC office-to-residential conversion faces structural failure
A significant structural issue occurred at the former Pfizer world headquarters in New York City, which is undergoing conversion into residential apartments. Two support columns buckled on the 21st floor, leading to eva…
-
Anduril founder: US universities are failing engineers, ceding advantage to China
Anduril founder Palmer Luckey has expressed concern that the U.S. university system is failing to adequately train engineers, potentially ceding a critical advantage to China. He argues that American institutions have s…
-
Eli Lilly invests $40M in AI drug firm Absci for baldness treatment
Eli Lilly has invested $40 million in Absci, a generative AI drug discovery company, as part of a larger $100 million stock offering. Absci utilized AI to design ABS-201, an injectable antibody targeting a hormone recep…
-
Screen for undervalued stocks using Python's Finance Toolkit
This article details how to use the Finance Toolkit Python library to systematically screen for undervalued stocks. It outlines a three-step process: first, pulling key valuation multiples like P/E, P/FCF, P/B, and EV/E…
-
CFOs show paradox of promise vs. pessimism amid economic downturn
A recent Deloitte survey reveals a divergence in sentiment among North American CFOs, with a majority expressing optimism about their own companies' financial futures despite a worsening economic outlook. This confidenc…
-
Nike names new CFO; US pressures Meta on AI model review
Nike has appointed David M. Denton as its new Chief Financial Officer, effective August 17th. Denton, who previously served as CFO for Pfizer, brings over 30 years of financial leadership experience. He will succeed Mat…
-
Pfizer transforms manufacturing with AI-centric MES, MIT Sloan reports
MIT Sloan has detailed Pfizer's successful transition to an AI-centric Manufacturing Execution System (MES). The company shifted its approach from top-down implementation to bottom-up enablement, fostering greater trust…
-
Temasek reshapes leadership with CFO Png Chin Yee moving to new role
Temasek, Singapore's state-owned investment firm, is undergoing a significant leadership restructuring. CFO Png Chin Yee will transition to a newly created role as president of Temasek Singapore, overseeing key local po…